Australia: Infrastructure and Innovations for Clinical Trials
Sponsors seeking venues for pharmaceutical research and development would do well to consider Australia – offering a highly favorable, stable environment and experienced, capable local expertise. This article is the second in a three-part series: Here, we examine the landscape for clinical trials, including infrastructure, government funding support and incentives, patient centricity, patient recruitment, and the adoption of innovation.
Interested in more? Check out part 1 and part 3.
Related Insights
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Related Insights
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021